CHAC1 exacerbates arsenite cytotoxicity by lowering intracellular glutathione levels

被引:0
作者
Sumi, Daigo [1 ]
Taguchi, Hiroki [1 ]
Takeuchi, Kumiko [1 ]
Fujishiro, Hitomi [1 ]
机构
[1] Tokushima Bunri Univ, Fac Pharmaceut Sci, Yamashiro Cho, Tokushima 7708514, Japan
关键词
Arsenite; Apoptosis; CHAC1; Glutathione; TRANSCRIPTION FACTOR; CELL APOPTOSIS; TRIOXIDE AS2O3; DNA-DAMAGE; IN-VITRO; LEUKEMIA; ACTIVATION; METHYLTRANSFERASE; MECHANISMS; EXPRESSION;
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
We here examined whether CHAC1 is implicated in arsenite (As(III))-induced cytotoxicity in HaCaT cells. We found that HaCaT cells in which the intracellular GSH levels were elevated by transfection with CHAC1 siRNA showed decreased sensitivity to As(III) compared to the control cells. Treatment with BSO (an inhibitor of GSH biosynthesis) abolished the decrease in sensitivity to As(III), suggesting that an increase in intracellular GSH levels was involved in the decrease in sensitivity to As(III) due to the decrease in the levels of CHAC1 expression. When we examined the expression of CHAC1 after exposure of HaCaT cells to As(III), the levels of CHAC1 were increased. Since CHAC1 is a proapoptotic factor, we examined appearance of apoptotic cells and cleavage of caspase-3 after exposure to As(III) to determine whether As(III)-induced CHAC1 up-regulation was involved in apoptosis induction. The results showed that induction of apoptosis by As(III) exposure was not detected in CHAC1 siRNA-transfected cells. Together, our findings indicate that CHAC1 is involved in the sen-sitivity of HaCaT cells to As(III) by regulating the intracellular GSH levels, and in particular, CHAC1 is involved in As(III)-induced apoptosis.
引用
收藏
页码:487 / 494
页数:8
相关论文
共 33 条
  • [1] Arsenic toxicology: Five questions
    Aposhian, HV
    Aposhian, MM
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (01) : 1 - 15
  • [2] Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors
    Chen, Duo
    Chan, Rosemarie
    Waxman, Samuel
    Jing, Yongkui
    [J]. CANCER RESEARCH, 2006, 66 (23) : 11416 - 11423
  • [3] Chen GQ, 1997, BLOOD, V89, P3345
  • [4] Chen GQ, 1996, BLOOD, V88, P1052
  • [5] Human CHAC1 Protein Degrades Glutathione, and mRNA Induction Is Regulated by the Transcription Factors ATF4 and ATF3 and a Bipartite ATF/CRE Regulatory Element
    Crawford, Rebecca R.
    Prescott, Eugenia T.
    Sylvester, Charity F.
    Higdon, Ashlee N.
    Shan, Jixiu
    Kilberg, Michael S.
    Mungrue, Imran N.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (25) : 15878 - 15891
  • [6] A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19
    Hayakawa, T
    Kobayashi, Y
    Cui, X
    Hirano, S
    [J]. ARCHIVES OF TOXICOLOGY, 2005, 79 (04) : 183 - 191
  • [7] ChaC glutathione specific γ-glutamylcyclotransferase 1 inhibits cell viability and increases the sensitivity of prostate cancer cells to docetaxel by inducing endoplasmic reticulum stress and ferroptosis
    He, Saifei
    Zhang, Miao
    Ye, Ying
    Zhuang, Juhua
    Ma, Xing
    Song, Yanan
    Xia, Wei
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (03)
  • [8] Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway
    Jing, YK
    Dai, J
    Chalmers-Redman, RME
    Tatton, WG
    Waxman, S
    [J]. BLOOD, 1999, 94 (06) : 2102 - 2111
  • [9] Cytolethality of glutathione conjugates with monomethylarsenic or dimethylarsenic compounds
    Kojima, C
    Sakurai, T
    Waalkes, MP
    Himeno, S
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (10) : 1827 - 1832
  • [10] Arsenic: Signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity
    Kumagai, Yoshito
    Sumi, Daigo
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2007, 47 : 243 - 262